Patents by Inventor Manfred Stohrer

Manfred Stohrer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5998430
    Abstract: Compositions of the anticholinergic agent trospium chloride suitable for localized administration are provided, in the form of an aqueous solution having a pH-value of.gtoreq.4.5, that is prepared prior to administration. Methods of using the provided compositions for treating dysfunctions of the bladder and the urinary system are also provided.
    Type: Grant
    Filed: November 17, 1997
    Date of Patent: December 7, 1999
    Assignee: Dr. R. Pfleger Chemische Fabrik GmbH
    Inventors: Ulrich Schwantes, Albert Schaupp, Manfred Stohrer
  • Patent number: 5843016
    Abstract: A method of treating acute urinary outflow system obstruction caused by disease of the prostate gland by localised electromotive drug administration. The treatment comprises insertion within the prostatic urethra and within the bladder cavity of a urethral catheter which incorporates a specific electrode and is adapted to perform the electromotive administration of a drug or drug mixture into diseased prostatic tissues thereby resolving the pathologies without resorting to surgery.
    Type: Grant
    Filed: March 18, 1996
    Date of Patent: December 1, 1998
    Assignee: Physion S.r.L.
    Inventors: Franco Lugnani, Manfred Stohrer, Augustinus Kramer, Robert L. Stephen, Umberto Fontanella, Cino Rossi, Silvio Eruzzi
  • Patent number: 5779661
    Abstract: An intravesical method of treating dysfunctional bladder syndromes by Electromotive Drug Administration (EMDA) of local anaesthetic drugs, anti muscarinic drugs and sympathomimetic agents. The administration of said drugs combined with hydraulic bladder dilatation causes relaxation of the detrusor muscle, reversing the hypertonicity associated with dysfunctional bladder syndromes.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: July 14, 1998
    Assignee: Physion, S.r.l.
    Inventors: Robert L. Stephen, Manfred Stohrer, Umberto Fontanella, Donald P. Griffith, Franco Lugnani, Cino Rossi, Silvio Eruzzi
  • Patent number: 5532266
    Abstract: Novel arylacetamides of the formula I ##STR1## in which Q is R.sup.4 --CH(CH.sub.2 Z)--NA--, ##STR2## R.sup.1 is Ar, cycloalkyl with 3-7 C atoms or C.sub.4 -C.sub.8 -cycloalkyl-C.sub.1 -C.sub.7 -alkyl,R.sup.2 is Ar,R.sup.3 is H, OH, OA or A,R.sup.4 is A or phenyl which can optionally be substituted once or twice by F, Cl, Br, I, OH, OA, CF.sub.3, NO.sub.2, NH.sub.2, NHA, NHCOA, NHSO.sub.2 A or NA.sub.2,R.sup.5 and R.sup.6 are each, independently of one another, H, F, Cl, Br, I, OH, OA, CF.sub.3, NH.sub.2, NHA, NA.sub.2, NHCOA, NHCONH.sub.2, NO.sub.2 or taken together are methylenedioxy,A is alkyl with 1-7 C atoms, and physiologically acceptable salts thereof.
    Type: Grant
    Filed: May 30, 1995
    Date of Patent: July 2, 1996
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Rudolf Gottschlich, Karl-August Ackermann, Helmut Prucher, Christoph Seyfried, Hartmut Greiner, Gerd Bartoszyk, Frank Mauler, Manfred Stohrer, Andrew Barber